Stay updated on GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Sign up to get notified when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.

Latest updates to the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0.SummaryDifference0.1%

- Check43 days agoChange DetectedThe standard government funding/status notice was removed from the page. The study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check57 days agoChange DetectedNo additions or deletions were detected on the page; the Study Details content appears unchanged.SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check93 days agoChange DetectedThe page update appears to be a simple version bump from v3.0.2 to v3.1.0 with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Enter your email address, and we'll notify you when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.